Loading GMAB charts…
May we use analytics cookies to see how vpside is used, including anonymous session recordings? Accepting also loads the price chart, which sets its own cookies. Essential cookies are always on. Privacy
Loading GMAB comparable companies…
| GMABGenmab A/s(opens in a new tab) | — | $3.12B | +30.6% | 95.4% | 31.1% | — | — |
|---|---|---|---|---|---|---|---|
| AMRXAmneal Pharmaceuticals, Inc.(opens in a new tab) | $7.06B | $3.12B | +9.3% | 39.3% | 14.6% | 2.26× | 43.9× |
| UTHRUNITED THERAPEUTICS Corp(opens in a new tab) | $27.43B | $3.15B | +2.5% | 86.1% | 44.4% | 8.70× | 21.4× |
| BMRNBiomarin Pharmaceutical Inc.(opens in a new tab) | $11.38B | $3.41B | +11.2% | 76.1% | 4.4% | 3.34× | 158.2× |
| RDYDR Reddys Laboratories Ltd(opens in a new tab) | $11.82B | $3.80B | −1.2% | 52.8% | 15.0% | 3.11× | 24.3× |
| Medianpeers, excl. GMAB | $11.60B | $3.28B | +5.9% | 64.4% | 14.8% | 3.22× | 34.1× |